Product Information
CAPTOPRIL 12.5 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2477 per EA under NDC 00143117101. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
12.5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143117101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CAPTOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA074505On Market Since
2/13/1996
Pharmacological Classes
Price Statistics
The NADAC for CAPTOPRIL 12.5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2477 per EA |
|---|---|
| All-time high | $0.9925 (Sep 10, 2014) |
| All-time low | $0.1816 (Mar 19, 2025) |
| 52-week high | $0.4059 |
| 52-week low | $0.2477 |
| Median price | $0.6645 |
| Average price | $0.6129 |
| Largest weekly change | +125.8% (Aug 17, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAPTOPRIL 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 12.5 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2477 per EA (NDC 00143117101), effective Jun 24, 2026.
How has the price of CAPTOPRIL 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPTOPRIL 12.5 MG TABLET has declined 37.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CAPTOPRIL 12.5 MG TABLET?
Since Nov 28, 2013, the NADAC for CAPTOPRIL 12.5 MG TABLET has ranged from a low of $0.1816 (Mar 19, 2025) to a high of $0.9925 (Sep 10, 2014), with a median of $0.6645 per EA.
Are there cheaper alternatives to CAPTOPRIL 12.5 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CAPTOPRIL 12.5 MG TABLET, but none are currently priced below it.
Who manufactures CAPTOPRIL 12.5 MG TABLET?
CAPTOPRIL 12.5 MG TABLET (NDC 00143117101) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification